Hosted on MSN

What You Need to Know About ATTR-CM When You’re an Older Adult

ATTR-CM can be a life-changing diagnosis, and if youre an older adult, it can have an especially large impact on your quality of life. Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is a rare but ...
Hindustan Times

Republic Day function: Bihar to display tableau on superfood ‘Makhana’

Bihar’s superfood Makhana’s (foxnut) will be the highlight of the state’s tableau display on the 77th Republic Day on January 26, an official communique stated. The theme of the Bihar tableau is ...
STAT

Function Health has won over consumers. When will it publish evidence?

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...
Business Wire

New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM

− Cardiovascular Magnetic Resonance (CMR) and Echocardiographic Analyses Demonstrate that Treatment with Vutrisiran Resulted in Significant Changes on Multiple Functional and Structural Cardiac ...
GEN

Patient Dies After Treatment with Intellia CRISPR Therapy in Phase III Trial

Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...
Seeking Alpha

Intellia: Moving To 'Hold' Rating In Light Of Nex-Z Uncertainty In ATTR Patients (Downgrade)

The last time I spoke about Intellia Therapeutics (NTLA), it was with a Seeking Alpha article entitled "Nex-Z Advancement Remains On Track With Expanded ATTRv-PN Indication" With respect to this ...
FiercePharma

Alnylam's Amvuttra blows past estimates again as ATTR-CM launch gains traction

Alnylam’s closely watched launch of its rare disease drug Amvuttra continued to outpace Wall Street expectations. Riding its March expansion into the heart condition of transthyretin amyloid ...
The New England Journal of Medicine

Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy

Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a rare, multisystem, progressive, debilitating, and fatal disease characterized by tissue deposition of misfolded transthyretin ...
Healthline

How Does ATTR CM Progress? Your FAQs Answered

As transthyretin amyloid cardiomyopathy (ATTR-CM) progresses, it can cause more serious problems with the heart and other parts of the body. Talking with your doctor about how the condition may ...
Wall Street Journal

The Fed’s ‘Gain of Function’ Monetary Policy

Journal Editorial Report: The Fed Chief signals rate cuts are coming. As we saw during the Covid pandemic, lab-created experiments can wreak havoc when they escape their confines. Once released, they ...
MedPage Today

Transthyretin Amyloid Cardiomyopathy: What Is It and How Rare Is It Really?

While still considered a rare disease, transthyretin amyloid cardiomyopathy (ATTR-CM) is nevertheless emerging in more people than previously thought due to increased interest and improved access to ...